Lilly Pays US$2.4 B to Acquire Orna Therapeutics and its CAR-T Cell Therapies for Autoimmune Diseases
By Naini Anand
Pharma Deals Review: Vol 2026 Issue 3 (Table of Contents)
Published: 3 Mar-2026
DOI: 10.3833/pdr.v2026.i3.3002 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Lilly has entered into a definitive agreement to acquire Orna Therapeutics in a deal valued at approximately US$2...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS